vs
Amarin Corp plc（AMRN）与FLUSHING FINANCIAL CORP（FFIC）财务数据对比。点击上方公司名可切换其他公司
FLUSHING FINANCIAL CORP的季度营收约是Amarin Corp plc的1.3倍（$58.8M vs $45.1M），FLUSHING FINANCIAL CORP净利率更高（6.8% vs -23.3%，领先30.1%），FLUSHING FINANCIAL CORP同比增速更快（2597.7% vs 7.0%），过去两年FLUSHING FINANCIAL CORP的营收复合增速更高（13.7% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
弗拉格斯塔夫银行（Flagstar Bank, N.A.）是美国区域性金融服务控股集团，总部位于纽约希克斯维尔。2023年该行共运营395家分支机构，并于2024年2月21日完成全部分支机构的品牌统一，全部更名为Flagstar品牌。
AMRN vs FFIC — 直观对比
营收规模更大
FFIC
是对方的1.3倍
$45.1M
营收增速更快
FFIC
高出2590.7%
7.0%
净利率更高
FFIC
高出30.1%
-23.3%
两年增速更快
FFIC
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $58.8M |
| 净利润 | $-10.5M | $4.0M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 13.3% |
| 净利率 | -23.3% | 6.8% |
| 营收同比 | 7.0% | 2597.7% |
| 净利润同比 | 33.0% | 108.2% |
| 每股收益（稀释后） | — | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNFFIC
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $58.8M | ||
| Q3 25 | $49.7M | $58.6M | ||
| Q2 25 | $72.7M | $63.5M | ||
| Q1 25 | $42.0M | $58.1M | ||
| Q4 24 | $62.3M | $2.2M | ||
| Q3 24 | $42.3M | $51.9M | ||
| Q2 24 | $67.5M | $47.0M |
净利润AMRNFFIC
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $4.0M | ||
| Q3 25 | $-7.7M | $10.4M | ||
| Q2 25 | $-14.1M | $14.2M | ||
| Q1 25 | $-15.7M | $-9.8M | ||
| Q4 24 | $-48.6M | $-49.2M | ||
| Q3 24 | $-25.1M | $8.9M | ||
| Q2 24 | $1.5M | $5.3M |
毛利率AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNFFIC
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 13.3% | ||
| Q3 25 | -22.4% | 23.4% | ||
| Q2 25 | -22.0% | 29.8% | ||
| Q1 25 | -39.9% | -10.2% | ||
| Q4 24 | -84.3% | -3296.2% | ||
| Q3 24 | -59.5% | 22.1% | ||
| Q2 24 | -0.8% | 15.2% |
净利率AMRNFFIC
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 6.8% | ||
| Q3 25 | -15.6% | 17.8% | ||
| Q2 25 | -19.4% | 22.4% | ||
| Q1 25 | -37.4% | -16.9% | ||
| Q4 24 | -78.0% | -2258.9% | ||
| Q3 24 | -59.4% | 17.2% | ||
| Q2 24 | 2.3% | 11.3% |
每股收益（稀释后）AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.12 | ||
| Q3 25 | $-0.02 | $0.30 | ||
| Q2 25 | $-0.03 | $0.41 | ||
| Q1 25 | $-0.04 | $-0.29 | ||
| Q4 24 | $-0.12 | $-1.67 | ||
| Q3 24 | $-0.06 | $0.30 | ||
| Q2 24 | $0.00 | $0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $708.0M |
| 总资产 | $645.8M | $8.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNFFIC
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
股东权益AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $708.0M | ||
| Q3 25 | $458.9M | $711.2M | ||
| Q2 25 | $464.9M | $706.4M | ||
| Q1 25 | $473.7M | $702.9M | ||
| Q4 24 | $486.2M | $724.5M | ||
| Q3 24 | $531.4M | $666.9M | ||
| Q2 24 | $551.9M | $665.3M |
总资产AMRNFFIC
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $8.7B | ||
| Q3 25 | $659.8M | $8.9B | ||
| Q2 25 | $670.1M | $8.8B | ||
| Q1 25 | $655.7M | $9.0B | ||
| Q4 24 | $685.3M | $9.0B | ||
| Q3 24 | $750.6M | $9.3B | ||
| Q2 24 | $799.9M | $9.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $61.0M |
| 自由现金流经营现金流 - 资本支出 | — | $55.8M |
| 自由现金流率自由现金流/营收 | — | 94.9% |
| 资本支出强度资本支出/营收 | — | 8.9% |
| 现金转化率经营现金流/净利润 | — | 15.16× |
| 过去12个月自由现金流最近4个季度 | — | $104.7M |
8季度趋势，按日历期对齐
经营现金流AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $61.0M | ||
| Q3 25 | $-12.7M | $19.6M | ||
| Q2 25 | $16.6M | $25.8M | ||
| Q1 25 | $-12.5M | $6.9M | ||
| Q4 24 | $-13.3M | $12.4M | ||
| Q3 24 | $-2.4M | $5.4M | ||
| Q2 24 | $-2.7M | $9.6M |
自由现金流AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | — | $55.8M | ||
| Q3 25 | — | $19.3M | ||
| Q2 25 | — | $24.4M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | — | $4.8M | ||
| Q2 24 | — | $8.8M |
自由现金流率AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | — | 94.9% | ||
| Q3 25 | — | 33.0% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | — | 463.4% | ||
| Q3 24 | — | 9.3% | ||
| Q2 24 | — | 18.7% |
资本支出强度AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 106.0% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.7% |
现金转化率AMRNFFIC
| Q1 26 | — | — | ||
| Q4 25 | — | 15.16× | ||
| Q3 25 | — | 1.87× | ||
| Q2 25 | — | 1.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | -1.81× | 1.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
FFIC
暂无分部数据
